Effectieve immunotherapie tegen borstkanker KWF Kankerbestrijding


De Visser, Karin, PhD TRR332 neutrophils

Karin de Visser @deVisserKarin Tumor Immunologist @NKI_nl @oncodeinstitute interested in crosstalk between the immune system and breast cancer, metastasis, myeloid and adaptive immune cells Amsterdam, The Netherlandsnki.nl/research/resea… Joined December 2022 40Following 397Followers Tweets Tweets & replies Media Likes Karin de Visser's Tweets


exto.nl Encagement met Don Satijn1 van Karin de Visser

Karin E. de Visser Johanna A. Joyce DOI: https://doi.org/10.1016/j.ccell.2023.02.016 The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth Summary Cancers represent complex ecosystems comprising tumor cells and a multitude of non-cancerous cells, embedded in an altered extracellular matrix.


exto.nl City Blues van Karin de Visser

KARIN DE VISSER OUR RESOURCES Resources. Our team has developed a preclinical mouse model of invasive lobular breast cancer metastasis. We used this model to unravel mammary tumor-induced pro-metastatic inflammation (IL-17-producing γδ T cells and.


Birgit Speulman Karin de Visser Birgit Speulman

Karin de Visser Professor by special appointment Tumor Immunology Name Prof.dr. K.E. de Visser E-mail [email protected] Overview Profile Contact Publications Ancillary activities


Karin de Visser, kunstenaar van de maand augustus 2021 » Art & Jazz

In February Karin de Visser received a VICI grant from NWO to investigate how genetic changes in breast cancer cells influence the immune system of patients. De Visser's research group is also affiliated with the Oncode Institute.


Karin de Visser YouTube

Karina Elizabeth de Visser (Karin de Visser, 1975), [1] also named "Karin E. de Visser", is a researcher at the Netherlands Cancer Institute. Her research considers metastatic formation and how the immune system influences how people respond to cancer treatment. Early life and education


Rotterdam Contemporary Art Fair 2017

Prof. dr. Karin E. de Visser is group leader at the Division of Tumor Biology & Immunology at the Netherlands Cancer Institute, alongside her appointment as group leader at Oncode Institute and as full professor of Experimental Immunobiology of Cancer at Leiden University. The overall goal of her research is to dissect how the immune system influences metastatic breast cancer.


Projectleider Karin Visser vertelt hoe de regio Amsterdam de subsidieaanvraag aanpakt Babyconnect

KARIN DE VISSER Karin de Visser Group leader +31 20 512 6104 [email protected] Prof. dr. Karin E. de Visser obtained her PhD at the Division of Immunology at the Netherlands Cancer Institute in Amsterdam in the field of tumor immunotherapy.


Karin Visser directeur Toezicht en Opsporing bij ILT Nieuwsbericht Algemene Bestuursdienst

Bekijk het profiel van Karin de Visser op LinkedIn, de grootste professionele community ter wereld. Karin heeft 7 functies op zijn of haar profiel. Bekijk het volledige profiel op LinkedIn om de connecties van Karin en vacatures bij vergelijkbare bedrijven te zien.


Oratie Karin de Visser ‘Het immuunsysteem is een tweesnijdend zwaard’

615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404 USA Telephone: Email: Karin E. de Visser is a member of the Tumor Microenvironment Working Group Steering Committee.


Even voorstellen, Karin de Visser Alkmaars Kanaal

Karin E. de Visser Nature Reviews Cancer 16 , 431-446 ( 2016) Cite this article 34k Accesses 1045 Citations 21 Altmetric Metrics Key Points In patients with solid cancers, neutrophils expand.


exto.nl Encagement van Karin de Visser

Karin E de Visser Netherlands Cancer Institute · Division of Immunology PhD Connect with experts in your field Join ResearchGate to contact this researcher and connect with your scientific.


Karin De Visser, Working On Threat Famous artists, Artist at work, Studio

Hannah Garner 1 , Karin E de Visser 2 3 Affiliations 1 Division of Tumour Biology & Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands.. Leiden University Medical Centre, Leiden, Netherlands. [email protected]. PMID: 32024984 DOI: 10.1038/s41577-019-0271-z Abstract.


Karin de Visser Twentyfour Seven

Karin E. de Visser's research while affiliated with Netherlands Cancer Institute and other places Overview What is this page? This page lists the scientific contributions of an author, who.


Inaugural lecture Karin de Visser Oncode Institute

Karin E de Visser 1 , Johanna A Joyce 2 Affiliations 1 Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands. Electronic address: [email protected].


Karin de Visser Suspension

Karin E. de Visser Nature Reviews Immunology 20 , 483-497 ( 2020) Cite this article 20k Accesses 205 Citations 108 Altmetric Metrics Abstract Metastatic disease is responsible for.